Neuropace Inc (NPCE NASDAQ) stock market data APIs
$9.8557
0.11(1.1%)
as of October 30, 2025
Try our APIs with
free plan!
Neuropace Inc Financial Data Overview
Price chart is built with
Anychart
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Prev. Close
9.8557
Open
9.9672
High
10.0982
Low
9.7114
52 wk Range
6.03-18.975
Market Cap
335 M
Shares Outstanding
33 081 K
Revenue
88 570 K
EPS
0
Beta
1.915
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Neuropace Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neuropace Inc data using free add-ons & libraries
Get Neuropace Inc Fundamental Data
Neuropace Inc Fundamental data includes:
- Net Revenue: 88 570 K
- EBITDA: -19 659 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: -0.1959
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuropace Inc News
New
3 Companies That May Be Trading Below Their Estimated Value
As the U.S. stock market experiences mixed performance amid significant economic events, such as trade discussions between President Trump and China's Xi Jinping and earnings reports from major tech c...
Discover DoorDash And 2 Stocks That May Be Trading Below Their Estimated Value
As the U.S. markets navigate a period of mixed signals, with recent interest rate cuts and record highs in tech-heavy indices like the Nasdaq, investors are keenly observing opportunities that may ari...
October 2025's Noteworthy Stocks Estimated Below Their Intrinsic Value
As the U.S. stock market concludes a volatile week with major indices posting gains, investors are navigating through concerns about banking sector health and trade tensions with China. In this enviro...
3 Compelling Stocks Estimated To Be Trading Up To 31.6% Below Intrinsic Value
As the U.S. stock market navigates through investor concerns over banking sector health and geopolitical tensions, major indices like the Dow Jones, S&P 500, and Nasdaq have shown modest gains amidst ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
